Funabashi, Japan

Yukio Asaka

This inventor holds 1 USPTO granted patent. Top assignees: Nissan Chemical Corporation, Peptidream Inc.. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yukio Asaka: Innovator in Peptide Production

Introduction

Yukio Asaka is a notable inventor based in Funabashi, Japan. He has made significant contributions to the field of peptide chemistry, particularly through his innovative methods for producing peptide compounds. His work has implications in various scientific and industrial applications.

Latest Patents

Yukio Asaka holds a patent for a "Method for producing peptide compound." This invention provides a method for producing a peptide containing an N-alkylamino acid, which involves three key steps. Step (1) includes mixing an N-terminal protected amino acid or peptide with a carboxylic acid halide or halogenated alkyl formate. Step (2) involves mixing an amino acid or peptide, where the N-terminal and C-terminal are unprotected, with a trialkylsilylating agent. Finally, Step (3) combines the products obtained from Steps (1) and (2).

Career Highlights

Throughout his career, Yukio Asaka has worked with prominent companies such as Peptidream Inc. and Nissan Chemical Corporation. His experience in these organizations has allowed him to refine his expertise in peptide synthesis and related technologies.

Collaborations

Yukio Asaka has collaborated with notable individuals in his field, including Ayumu Matsuda and Douglas Robert Cary. These collaborations have contributed to the advancement of research and development in peptide production.

Conclusion

Yukio Asaka's innovative methods in peptide production highlight his significant contributions to the field of chemistry. His patent and collaborations reflect his dedication to advancing scientific knowledge and technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…